JP2020520986A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020520986A5 JP2020520986A5 JP2019565425A JP2019565425A JP2020520986A5 JP 2020520986 A5 JP2020520986 A5 JP 2020520986A5 JP 2019565425 A JP2019565425 A JP 2019565425A JP 2019565425 A JP2019565425 A JP 2019565425A JP 2020520986 A5 JP2020520986 A5 JP 2020520986A5
- Authority
- JP
- Japan
- Prior art keywords
- drug composition
- substituted
- lung infection
- composition according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*NC(C)(CC(OC(C1O)C(Oc(c(Oc(ccc(C(*)C(C(NC(C(*)=O)c2cc(O)c(*)c(O)c2-c2cc(C3NC(C4NC(C(CC(N)=O)NC(C(C(c(cc5)c6)O)NC(C(CC(C)C)NC)=O)=O)=O)=O)ccc2O)=O)NC3=O)c2)c2Cl)cc4c2)c2Oc5c6Cl)OC(CO)C1O)OC1C)C1O Chemical compound C*NC(C)(CC(OC(C1O)C(Oc(c(Oc(ccc(C(*)C(C(NC(C(*)=O)c2cc(O)c(*)c(O)c2-c2cc(C3NC(C4NC(C(CC(N)=O)NC(C(C(c(cc5)c6)O)NC(C(CC(C)C)NC)=O)=O)=O)=O)ccc2O)=O)NC3=O)c2)c2Cl)cc4c2)c2Oc5c6Cl)OC(CO)C1O)OC1C)C1O 0.000 description 2
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762509378P | 2017-05-22 | 2017-05-22 | |
| US62/509,378 | 2017-05-22 | ||
| US201762518280P | 2017-06-12 | 2017-06-12 | |
| US62/518,280 | 2017-06-12 | ||
| US201762560413P | 2017-09-19 | 2017-09-19 | |
| US62/560,413 | 2017-09-19 | ||
| PCT/US2018/033953 WO2018217800A1 (en) | 2017-05-22 | 2018-05-22 | Glycopeptide derivative compounds and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020520986A JP2020520986A (ja) | 2020-07-16 |
| JP2020520986A5 true JP2020520986A5 (cg-RX-API-DMAC7.html) | 2021-07-26 |
| JP7165146B2 JP7165146B2 (ja) | 2022-11-02 |
Family
ID=64395938
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565425A Expired - Fee Related JP7165146B2 (ja) | 2017-05-22 | 2018-05-22 | グリコペプチド誘導体化合物およびそれらの使用 |
| JP2019565468A Active JP7210476B2 (ja) | 2017-05-22 | 2018-05-22 | リポ‐グリコペプチド可切断性誘導体及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565468A Active JP7210476B2 (ja) | 2017-05-22 | 2018-05-22 | リポ‐グリコペプチド可切断性誘導体及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20200368312A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3634464A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7165146B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102661786B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN110996984A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2018271873B2 (cg-RX-API-DMAC7.html) |
| BR (2) | BR112019024549A2 (cg-RX-API-DMAC7.html) |
| GB (2) | GB2577420B (cg-RX-API-DMAC7.html) |
| IL (2) | IL270685B (cg-RX-API-DMAC7.html) |
| WO (2) | WO2018217808A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0811530B1 (pt) | 2007-05-14 | 2019-01-02 | Research Foundation Of State Univ Of New York | composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície |
| GB2577420B (en) | 2017-05-22 | 2022-07-06 | Insmed Inc | Glycopeptide derivative compounds and uses thereof |
| NL2023883B1 (en) * | 2019-09-24 | 2021-04-26 | Univ Leiden | Antibiotic compounds |
| US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
| WO2023094994A1 (en) * | 2021-11-24 | 2023-06-01 | Cumberland Pharmaceuticals Inc | Methods for the prevention or treatment of anthrax infection |
| CN121270649A (zh) * | 2024-07-03 | 2026-01-06 | 烟台新药创制山东省实验室 | 一类万古霉素衍生物、其制备方法、药物组合物和用途 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4639433A (en) | 1985-08-14 | 1987-01-27 | Eli Lilly And Company | Glycopeptide derivatives |
| EP0273727A3 (en) * | 1986-12-30 | 1990-01-17 | Smithkline Beecham Corporation | Glycosylated glycopeptides |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| PT101450B (pt) | 1994-02-02 | 1999-11-30 | Hovione Produtos Farmaceuticos | Novo dispositivo para inalacao |
| US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US6001336A (en) | 1996-12-31 | 1999-12-14 | Inhale Therapeutic Systems | Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof |
| ATE248583T1 (de) | 1997-09-29 | 2003-09-15 | Nektar Therapeutics | In dosierinhalatoren verwendbare, stabilisierte zubereitungen |
| WO1999016420A1 (en) | 1997-09-29 | 1999-04-08 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in nebulizers |
| US6518242B1 (en) * | 1998-02-20 | 2003-02-11 | Theravance, Inc. | Derivatives of glycopeptide antibacterial agents |
| WO1999063929A2 (en) * | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
| UA73924C2 (en) | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
| US6392012B1 (en) * | 1998-12-23 | 2002-05-21 | Advanced Medicine, Inc. | Glycopeptide derivatives and pharmaceutical compositions containing the same |
| PT1181069E (pt) | 1999-05-28 | 2006-11-30 | Nektar Therapeutics | Dispositivo e método para a administração de uma dose calibrada de medicamento em aerosol |
| US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| WO2001057071A2 (en) | 2000-02-04 | 2001-08-09 | Advanced Medicine, Inc. | Glycopeptide derivatives having antibiotic activity |
| AU2001238180B8 (en) | 2000-02-11 | 2006-07-27 | Eli Lilly And Company | Selective N-acylation of A82846 glycopeptide analogs |
| PT1280520E (pt) | 2000-05-10 | 2014-12-16 | Novartis Ag | Pós à base de fosfolípidos para administração de fármacos |
| UA75083C2 (uk) * | 2000-06-22 | 2006-03-15 | Тераванс, Інк. | Похідні глікопептидфосфонатів |
| TWI312785B (en) * | 2001-08-24 | 2009-08-01 | Theravance Inc | Process for preparing vancomycin derivatives |
| AU2003287605A1 (en) * | 2002-11-12 | 2004-06-03 | Enzon Pharmaceuticals, Inc. | Polymeric prodrugs of vancomycin |
| WO2004110473A1 (en) | 2003-05-27 | 2004-12-23 | Theravance, Inc. | Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| TWI342312B (en) * | 2003-10-22 | 2011-05-21 | Theravance Inc | Hydrochloride salts of a glycopeptide phosphonate derivative |
| US20070185015A1 (en) * | 2005-02-28 | 2007-08-09 | Chiron Corporation and North China Pharmaceutical Corporation | Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| US7632918B2 (en) * | 2005-02-28 | 2009-12-15 | Novartis Vaccines And Diagnostics, Inc. | Semi-synthetic glycopeptides with antibiotic activity |
| KR20100060004A (ko) * | 2007-09-25 | 2010-06-04 | 노파르티스 아게 | 에어로졸화된 반코마이신과 같은 의약에 의한 폐 질병의 치료 |
| MX2010004389A (es) * | 2007-10-23 | 2010-05-20 | Transave Inc | Formulaciones de vancomicina liposomales. |
| EP2238102A4 (en) * | 2007-12-26 | 2011-03-09 | Lead Therapeutics Inc | NEW HALF-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS |
| WO2010048340A2 (en) * | 2008-10-24 | 2010-04-29 | Lead Therapeutics, Inc. | Novel semi-synthetic glycopeptides as antibacterial agents |
| GB2465863A (en) * | 2008-12-05 | 2010-06-09 | Lead Therapeutics Inc | Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections |
| AU2010229721A1 (en) * | 2009-03-26 | 2011-10-06 | Pulmatrix, Inc. | Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis |
| PT2424559T (pt) * | 2009-04-28 | 2024-04-30 | Melinta Therapeutics Llc | Métodos de tratamento de infeções bacterianas utilizando oritavancina |
| SG195038A1 (en) * | 2011-05-19 | 2013-12-30 | Savara Inc | Dry powder vancomycin compositions and associated methods |
| US9572774B2 (en) * | 2011-05-19 | 2017-02-21 | Savara Inc. | Dry powder vancomycin compositions and associated methods |
| JP6254525B2 (ja) | 2011-08-05 | 2017-12-27 | ザ スクリプス リサーチ インスティテュート | バンコマイシン耐性菌株に対して有効なグリコペプチド系抗生物質類似体 |
| PL2852391T3 (pl) * | 2012-05-21 | 2022-04-11 | Insmed Incorporated | Układy do leczenia infekcji płuc |
| CA2891487A1 (en) * | 2012-11-29 | 2014-06-05 | Insmed Incorporated | Stabilized vancomycin formulations |
| GB201402267D0 (en) * | 2014-02-10 | 2014-03-26 | Cambridge Entpr Ltd | Antibacterial agents |
| CN105085636B (zh) * | 2014-05-19 | 2020-05-01 | 中国医学科学院药物研究所 | 一类万古霉素衍生物、其制备方法及其在抗菌方面的应用 |
| WO2016007855A1 (en) | 2014-07-10 | 2016-01-14 | The Scripps Research Institute | N- (hydrophobe-substituted) vancosaminyl [ψ[c(=nh) nh] tpg4] vancomycin and [ψ[ch2nh]tpg4] vancomycin |
| CN107325159A (zh) | 2016-04-29 | 2017-11-07 | 中国科学院上海药物研究所 | 一类万古霉素衍生物、其制备方法、药物组合物和用途 |
| WO2018008197A1 (ja) | 2016-07-07 | 2018-01-11 | 日東電工株式会社 | 反射層および蛍光体層付光半導体素子 |
| CA3042039C (en) | 2016-10-31 | 2023-09-26 | The Scripps Research Institute | Peripheral modifications on pocket-redesigned vancomycin analogs synergistically improve antimicrobial potency and durability |
| GB2577420B (en) | 2017-05-22 | 2022-07-06 | Insmed Inc | Glycopeptide derivative compounds and uses thereof |
-
2018
- 2018-05-22 GB GB1917677.5A patent/GB2577420B/en active Active
- 2018-05-22 IL IL270685A patent/IL270685B/en unknown
- 2018-05-22 GB GB1917675.9A patent/GB2577419B/en active Active
- 2018-05-22 JP JP2019565425A patent/JP7165146B2/ja not_active Expired - Fee Related
- 2018-05-22 KR KR1020197035481A patent/KR102661786B1/ko active Active
- 2018-05-22 WO PCT/US2018/033963 patent/WO2018217808A1/en not_active Ceased
- 2018-05-22 US US16/615,232 patent/US20200368312A1/en not_active Abandoned
- 2018-05-22 US US16/615,214 patent/US11071769B2/en not_active Expired - Fee Related
- 2018-05-22 CN CN201880048300.3A patent/CN110996984A/zh active Pending
- 2018-05-22 BR BR112019024549A patent/BR112019024549A2/pt not_active Application Discontinuation
- 2018-05-22 IL IL270686A patent/IL270686B/en unknown
- 2018-05-22 CN CN201880047233.3A patent/CN110891590B/zh active Active
- 2018-05-22 EP EP18805177.5A patent/EP3634464A4/en active Pending
- 2018-05-22 AU AU2018271873A patent/AU2018271873B2/en active Active
- 2018-05-22 KR KR1020197035485A patent/KR102661790B1/ko active Active
- 2018-05-22 EP EP18805750.9A patent/EP3630154B1/en active Active
- 2018-05-22 WO PCT/US2018/033953 patent/WO2018217800A1/en not_active Ceased
- 2018-05-22 BR BR112019024472-7A patent/BR112019024472A2/pt not_active Application Discontinuation
- 2018-05-22 AU AU2018273887A patent/AU2018273887B2/en active Active
- 2018-05-22 JP JP2019565468A patent/JP7210476B2/ja active Active
-
2021
- 2021-06-10 US US17/344,322 patent/US11857597B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEAP202416435A (en) | Anti-viral compounds | |
| CL2021001042A1 (es) | Nuevos compuestos antihelmínticos | |
| MX2020007633A (es) | Péptidos macrocíclicos contra acinetobacter baumannii. | |
| JP2016513688A5 (cg-RX-API-DMAC7.html) | ||
| JP2013537229A5 (cg-RX-API-DMAC7.html) | ||
| JP2016531871A5 (cg-RX-API-DMAC7.html) | ||
| CO2020013876A2 (es) | Nuevos derivados de quinolina | |
| CR20200148A (es) | Compuestos monobactámicos cromados para el tratamiento de infecciones bacterianas | |
| JP2018524406A5 (cg-RX-API-DMAC7.html) | ||
| JP2020520987A5 (cg-RX-API-DMAC7.html) | ||
| MX2025003905A (es) | Tiosulfato de sodio anhidro y formulaciones de este | |
| PH12022553420A1 (en) | Amidopyrimidone derivatives | |
| JP2017502984A5 (cg-RX-API-DMAC7.html) | ||
| BR112015004698A2 (pt) | combinações parasiticidas de isoxazolina espirocíclica | |
| JP2016505044A5 (cg-RX-API-DMAC7.html) | ||
| CY1124943T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν rpl554 σε hfa-134a για χορηγηση με εισπνοη | |
| BRPI0719920B8 (pt) | derivado de quinolina, sua composição farmacêutica, seu uso, seu processo de preparação, combinação e produto compreendendo o mesmo e composto intermediário | |
| ZA202301937B (en) | Compounds | |
| MX2022012652A (es) | Nuevos compuestos antihelminticos. | |
| BR0210667A (pt) | Derivados de oxazolidinonas como agentes antibacterianos | |
| JP2022501434A5 (cg-RX-API-DMAC7.html) | ||
| BR112019024549A2 (pt) | compostos derivados de glicopeptídeo e usos dos mesmos | |
| AR126191A1 (es) | Compuestos | |
| JP2020536966A5 (cg-RX-API-DMAC7.html) | ||
| JP2017516835A5 (cg-RX-API-DMAC7.html) |